Naval Medical Research and Development

Active

Assistance listing
12.340
Agency
Grant awards
6 $194,055,831 in federal obligations

Program facts

Assistance type
  • Cooperative Agreement
Treasury account
  • 17-1319-0-1-051
More information

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The Department of the Navy Bureau of Medicine and Surgery funds basic and applied medical research to enhance health, safety, readiness, and performance of Navy and Marine Corps personnel through cooperative agreements and contracts with educational and research institutions, with the most recent grant award dated September 30, 2023 (CFDA 12.340).

Program activity remains sparse but consistent. Six awards totaling $194.1 million have been obligated since 2014, with grant awards averaging roughly one per year over the past five years, though the distribution is uneven (single awards in 2014, 2017, and 2018; two in 2019; one in 2023). The portfolio is entirely cooperative agreements. The Department of the Navy Bureau of Medicine and Surgery dominates funding, accounting for five awards valued at $193.7 million; the Defense Health Agency provided one award of $365 thousand.

Award magnitudes range widely. Recent large cooperative agreements include research and development of protective vaccines and countermeasures against infectious disease agents of military importance ($82.3 million obligated through September 2029), the Austere Environment Consortium for Enhanced Sepsis Outcomes program ($43.6 million obligated through September 2025), and operational and undersea medicine research ($14.8 million obligated through September 2029). A smaller cooperative agreement supporting HIV prevention in Ukraine's armed forces was awarded $365 thousand with completion scheduled for November 2024.

The program funds collaborative research addressing Navy-specific operational health challenges: protective vaccines and countermeasures targeting malaria, rickettsial pathogens, multi-drug resistant bacteria, and emerging viral diseases; sepsis prevention and treatment in austere environments; undersea medicine; regenerative medicine; and neurotrauma research. Clinical trials supporting FDA approval of novel countermeasures for warfighter use also fall within scope.

Recent opportunities posted in 2019 solicited cooperative agreements for vaccine development, sepsis outcomes research, and clinical trials, with typical due dates falling 30 to 40 days after posting. No current opportunities appear in the source. White papers are reviewed within 60 to 90 days; formal proposals typically receive notification within six months, with awards following within four months. Applicants must be institutions or organizations; individuals are ineligible. Maximum project periods are five years, and records must be maintained for three years following final reimbursement.

Objective and description

Objective

To enhance the health, safety, readiness, and performance of Navy and Marine Corps personnel through basic and applied medical research executed largely through grants, cooperative agreements, and contracts with civilian educational and research inst

Description

To enhance the health, safety, readiness, and performance of Navy and Marine Corps personnel through basic and applied medical research executed largely through grants, cooperative agreements, and contracts with civilian educational and research institutions/organizations.

Eligibility

Applicant eligibility

Applicants must be an institution/organization. Applications will not be accepted from individuals.

Beneficiary eligibility

Beneficiaries are relatively independent investigators associated with an applicant institution/organization.

Uses of assistance

Recipients are required to conform to their accepted research protocol and are usually required to submit some form of annual or project report. Project support is limited to fundamental research which is defined as basic and applied research aimed at sustaining the technology base or understanding a biological- medical process, thereby providing a technological edge in solving complex biological-medical problems and countering future military medical threats. Some grants are also awarded to support conferences and symposiums.

Length and time phasing of assistance

The length of time for which support is requested should be consistent with the nature and complexity of the proposed research. The maximum period acceptable for a research proposal is 5 years. Funds are normally released on a quarterly basis.

How to apply

Preapplication coordination

White papers or pre-proposals may be required prior to full application submission.

Criteria for selecting proposals

Proposals are selected for funding based on the evaluation criteria listed in the Naval Medical Logistics Command's Broad Agency Announcement (BAA) or Program Announcements (PAs). The BAA and PAs can be viewed at the Grants.gov website.

Award procedure

Proposals are evaluated by in-house committee or by a combination of in-house and extramural review committees against the evaluation criteria listed in the Broad Agency Announcement (BAA) or Program Announcement (PA). The final stage of evaluation is the establishment of an order of merit in which all competing proposals are ranked on the basis of their respective military relevance and scientific merit evaluations. Award amount will be negotiated with those proposals recommended for funding. Awards depend upon the availability of funds and the priority which the Navy determines to exist at the time of award.

Time to approval or disapproval

White papers or pre-proposals are normally reviewed within 60 to 90 days. Formal proposals are usually reviewed and notifications received within 6 months from submission. Grant award dates are normally within 4 months from notification.

Renewals

Once a grant or cooperative agreement is awarded, any follow-on research proposal is treated as a new request. Follow-on work should allow for the review time noted above.

Grant opportunities

Grant awards

Top recipients by federal obligations

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 $10,009,912
FY2025 $7,560,865
FY2024 $15,202,007
FY2023 $13,827,252
FY2022 $12,272,094
FY2021 $45,949,857
FY2020 $17,446,792
FY2019 $21,368,886
FY2018 $26,725,765
FY2017 $11,082,002
FY2016 $4,519,720
FY2015 $6,025,180
FY2014 $2,065,500
Show all 13

Quick answers

What is Assistance Listing 12.340?

Assistance Listing 12.340 is Naval Medical Research and Development, a federal grant program run by Department of the Navy (Department of Defense).

What is the CFDA number for Naval Medical Research and Development?

Its CFDA number is 12.340: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 12.340 awarded?

6 grant awards under 12.340 have obligated $194,055,831 in federal funds to 2 recipients.

Who receives the most funding from 12.340?

The recipients obligated the most under Naval Medical Research and Development are The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. ($193,690,831) and International Non-Profit Organization "International Institute For HIV / Aids And Tuberculosis" ($365,000).

How much did 12.340 obligate in fiscal year 2025?

Grants under 12.340 obligated $7,560,865 in federal funds in fiscal year 2025.

Are there open grant opportunities under 12.340?

No opportunity listed under 12.340 is open now. The latest, Conduct of Clinical Trials to Facilitate the Development and Approval of Novel Countermeasures (vaccines, devices, drugs) for Use by the Warfighter, was posted on October 9, 2019.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program